ENZO BIOCHEM INC
9.87%
5,175,913
316253
294100102
Jun 22, 2025
Jun 25, 2025, 06:00 PM
Reporting Persons (9)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Raymond Harbert | Individual | 9.87% | 5,175,913 | 0 | 5,175,913 |
| Harbert Fund Advisors, Inc. | CO | 9.87% | 5,175,913 | 0 | 5,175,913 |
| Harbert Management Corporation | CO | 9.87% | 5,175,913 | 0 | 5,175,913 |
| Jack Bryant | Individual | 9.87% | 5,175,913 | 0 | 5,175,913 |
| Kenan Lucas | Individual | 9.87% | 5,175,913 | 0 | 5,175,913 |
| Harbert Discovery Co-Investment Fund I, LP | Partnership | 6.51% | 3,412,420 | 0 | 3,412,420 |
| Harbert Discovery Co-Investment Fund I GP, LLC | Other | 6.51% | 3,412,420 | 0 | 3,412,420 |
| Harbert Discovery Fund GP, LLC | Other | 3.36% | 1,763,493 | 0 | 1,763,493 |
| Harbert Discovery Fund, LP | Partnership | 3.36% | 1,763,493 | 0 | 1,763,493 |
Disclosure Items (5)
Common Stock, par value $0.01 per share
ENZO BIOCHEM INC
60 EXECUTIVE BLVD, FARMINGDALE, NY, 11735
See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of shares of Common Stock and percentages of the shares of Common Stock beneficially owned by each Reporting Person. The percentages used in this Schedule 13D are calculated based upon 52,432,129 shares of Common Stock outstanding as of June 19, 2025, as disclosed in the Merger Agreement.
Item 4 of this Amendment No. 15 is incorporated herein by reference.
Exhibit 99.13: Form of Voting and Support Agreement, dated as of June 23, 2025 (incorporated by reference to Exhibit 10.2 to the Issuer's Current Report on Form 8-K filed on June 24, 2025).